Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

538 ARTÍCULOS , VIENDO DEL 166 AL 180

Technologies Assessing Limb Bradykinesia in Parkinson's Disease

Hasan H, Athauda DS, Foltynie T, Noyce AJ.

J Parkinsons Dis. 2017;7(1):65-77. doi: 10.3233/JPD-160878.

Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors

Ledonne A, Mercuri NB.

Front Cell Neurosci. 2017 Feb 8;11:27. doi: 10.3389/fncel.2017.00027. eCollection 2017.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24.

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE.

Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316.

Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

Giannoccaro MP, La Morgia C, Rizzo G, Carelli V.

Mov Disord. 2017 Mar;32(3):346-363. doi: 10.1002/mds.26966. Epub 2017 Mar 2.

The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice

Loddo G, Calandra-Buonaura G, Sambati L, Giannini G, Cecere A, Cortelli P, Provini F.

Front Neurol. 2017 Feb 16;8:42. doi: 10.3389/fneur.2017.00042. eCollection 2017.

Diagnosing the frontal variant of Alzheimer's disease: a clinician's yellow brick road

Sawyer RP, Rodriguez-Porcel F, Hagen M, Shatz R, Espay AJ.

J Clin Mov Disord. 2017 Mar 2;4:2. doi: 10.1186/s40734-017-0052-4. eCollection 2017.

Parkinson's Disease: From Pathogenesis to Pharmacogenomics

Cacabelos R.

Int J Mol Sci. 2017 Mar 4;18(3):551. doi: 10.3390/ijms18030551.

Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers

Maeda T, Shimo Y, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H; J-FIRST group.

Parkinsonism Relat Disord. 2017 May;38:54-60. doi: 10.1016/j.parkreldis.2017.02.024. Epub 2017 Feb 21.

Remote modulation of network excitability during deep brain stimulation for epilepsy

Li DH, Yang XF.

Seizure. 2017 Apr;47:42-50. doi: 10.1016/j.seizure.2017.02.016. Epub 2017 Mar 4.

[Helpful instrumental examinations in idiopathic Parkinson's disease]

Walter U, Zach H, Liepelt-Scarfone I, Maetzler W.

Nervenarzt. 2017 Apr;88(4):365-372. doi: 10.1007/s00115-017-0289-z.

Effects of progressive resistance exercise in akinetic-rigid Parkinson's disease patients: a randomized controlled trial

Santos L, Fernandez-Rio J, Winge K, Barragán-Pérez B, González-Gómez L, Rodríguez-Pérez V, González-Díez V, Lucía A, Iglesias-Soler E, Dopico-Calvo X, Fernández-Del-Olmo M, Del-Valle M, Blanco-Traba M, Suman OE, Rodríguez-Gómez J.

Eur J Phys Rehabil Med. 2017 Oct;53(5):651-663. doi: 10.23736/S1973-9087.17.04572-5. Epub 2017 Mar 13.

Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson's Disease

Brotini S, Schievano C, Guidi L.

CNS Neurol Disord Drug Targets. 2017;16(6):705-713. doi: 10.2174/1871527316666170321124949.

Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex

Xu T, Wang S, Lalchandani RR, Ding JB.

Mov Disord. 2017 Apr;32(4):487-497. doi: 10.1002/mds.26938. Epub 2017 Mar 25.

Interaction of LRRK2 and α-Synuclein in Parkinson's Disease

Daher JP.

Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias